INTRODUCTION

5-Oxo-L-prolinase (5-OPase)¹ catalyzes the ATP-dependent cleavage of 5-oxoproline to L-glutamate: This reaction is highly unusual in that hydrolysis of ATP is required for the cleavage of a specific peptide bond (1). 5-OPase has been found in mammalian tissues (2), plants (3), and microorganisms (4, 5). Apparently homogeneous preparations of 5-OPase from rat kidney (6) and Pseudomonas putida (7) had been obtained in this laboratory and were used for physical characterization and for studies of catalytic mechanism. 5-OPase from rat kidney is composed of two apparently identical subunits that exhibit a molecular mass of 142 kDa on SDS-polyacrylamide gel electrophoresis (6). The enzyme is evidently a "sulfhydryl enzyme" (8) and has a number of sulfhydryl groups/monomer (6). The relationship between the essential sulfhydryl groups of the enzyme and its various catalytic activities have been probed (6). Unlike rat kidney 5-OPase, P. putida 5-OPase is composed of two different, reversibly dissociable protein components, A and B (7). Component A catalyzes an initial step in the reaction that involves 5-oxoproline and ATP (9). Component B may function as a catalyst that converts a phosphorylated form of 5-oxoproline to glutamate, or it might alter the conformation of Component A so as to facilitate the reaction (10, 11). Data are lacking, however, on the amino acid sequence of the enzyme from any source. Knowledge of the amino acid sequence of the enzyme and the cloning of the encoding cDNA are essential for further studies on the structure, mechanism of action, and physiological function of the enzyme.

This study was undertaken to elucidate the primary structure of rat kidney 5-OPase as preparation for the analysis of relationships between its structure and function. Peptides obtained from the purified rat kidney enzyme by enzymatic cleavage with Lys-C were used to design oligonucleotide probes that permitted cloning and sequencing of the cDNA encoding the complete protein. Protein representing the composite whole cDNA and truncated cDNA clones of the enzyme was also expressed in Escherichia coli, as confirmed by immunodetection with the rabbit antiserum against isolated rat kidney 5-OPase.

EXPERIMENTAL PROCEDURES

Frozen rat kidneys were obtained from Pel-Freez. Ultrogel AcA34 was from LKB. Phenyl- and aminohexyl-Sepharose were obtained from Pharmacia Biotech Inc.. DEAE-cellulose (DE-52) was from Whatman. The rat kidney gt11 cDNA library, premade rat kidney Marathon-Ready^TM cDNAs and Taq-start antibody were purchased from Clontech. DNA polymerase for PCR amplification (LD-PCR system) was from Boehringer Mannheim. Restriction endonucleases were from New England Biolabs Inc.. All radioisotopes were obtained from Amersham Corp. All chemicals and biologicals were purchased from Sigma unless noted otherwise.

Standard molecular biology techniques were used (12). Recombinant  DNA purification was performed as described (13). cDNA clones were subcloned into a Bluescript II KS vector (Stratagene) and sequenced by the dideoxy chain termination method (14) with Sequenase (United States Biochemical Corp.) using T3, T7 primers or specific internal primers. Automated DNA sequencing was carried out at the Cornell University DNA Synthesis and Sequencing Facility.

Enzyme activity was determined (6) in reaction mixtures containing (final volume, 0.5 ml) 100 mM Na-Hepes buffer (pH 8.0), 2 mM 5-oxo-L-proline (containing 100 cpm/nmol 5-oxo-L-[U-¹⁴C]proline), 5 mM ATP, 8 mM MgCl₂, 2 mM P-enolpyruvate, 150 mM KCl, 2 mM dithiothreitol, pyruvate kinase (5 units), and 5-OPase. After incubation at 37 °C for 30 min, the reaction mixtures were treated with 0.1 volume of 1 M HCl and placed at 0 °C for 5 min; an equal volume of 1 M Tris was then added. Denatured proteins were removed by centrifugation. Portions of the neutralized reaction mixtures were then analyzed for [¹⁴C]glutamate by liquid scintillation counting after removal of unreacted 5-oxoproline by chromatography on Dowex 50 (H⁺) as described (6). One unit of activity is defined as the amount of enzyme needed for the production of 1.0 µmol of glutamate/h under standard assay conditions.

Rat kidney 5-OPase was isolated from rat kidney homogenates using a procedure developed by Williamson and Meister (6). The homogenate was first centrifuged (16,200 × g for 90 min), and the proteins in the supernatant solution were fractionated by ammonium sulfate precipitation. The fraction containing the enzyme activity was then processed by a series of column chromatography steps, which sequentially involved DEAE-cellulose (DE-52), Ultrogel AcA34, phenyl-Sepharose, AH-Sepharose, and a second Ultrogel AcA34 step, as described (6). The preparation of the enzyme was further processed by a second DE-52 step and a third Ultrogel AcA34 chromatography step. An almost homogeneous (>90% pure) preparation of the enzyme with a specific activity of 72 units/mg was obtained in about 20% yield. Every step of the purification was followed by SDS-PAGE analysis. Quantitative assay for protein was done by the method of Bradford (15).

The 5-OPase (300 µg) was dialyzed for 24 h against two changes of phosphate-buffered saline and was concentrated to a final volume of 600 µl by vacuum dialysis against phosphate-buffered saline. An equal volume of complete Freund's adjuvant was added to the enzyme and mixed vigorously until the solution became very viscous. Two anesthetized New Zealand White rabbits (~1.8 kg) were injected intradermally at 20 sites (20-25 µl of emulsion each). A test bleed was performed 2 weeks after the primary immunization. The titer and specificity of the antibodies were determined by enzyme-linked immunosorbent assay and Western blot analysis, respectively.

Approximately 5 µg (1.5 pmol) of the protein isolated from rat kidney was electrophoresed on a 7.5% SDS-polyacrylamide gel and electrotransferred to a polyvinylidene difluoride membrane (16). The membrane was stained with Amido Black, and the protein band corresponding to 5-OPase (~140 kDa) was cut out for solid phase enzymatic digestion (endopeptidase Lys-C, enzyme/substrate, 1:10) (17). The microbore high performance liquid chromatography purification and sequencing of the peptides were carried out at the Rockefeller University Protein & Peptide Sequencing Facility.

A 29-mer degenerate oligonucleotide, oligonucleotide 1, (GTITTC(T)CAA(G)GAA(G)GAA(G)GCIGTIACIGAA(G)GC) was synthesized based on the peptide sequence VFQEEAVTEA in peptide 1 (Table I), end-labeled with [-³²P]ATP, and used to screen a gt11 rat kidney cDNA library. The probe is a mixture of 32 different 29-mer oligonucleotides corresponding to all codon combinations derived from peptide 1. Deoxyinosine (I) was substituted at the wobble positions in four of the codons. Duplicate filters were prehybridized at 42 °C for 3 h in prehybridization solution (6 × SSC, 5 × Denhardt's solution, 0.5% SDS, 0.01% sodium pyrophosphate, and 100 µg/ml denatured fragmented salmon sperm DNA), followed by hybridization at 50 °C for 18 h in the same solution containing 1.6 × 10⁵ cpm of ³²P-labeled probe/ml of hybridization buffer. The filters were washed with 2 × SSC containing 0.5% SDS for 20 min at room temperature with one change of the wash buffer, followed by washing with 2 × SSC and 0.2% SDS at 50 °C for 40 min with one change of the buffer. Of the ~5 × 10⁵ clones that were screened, three positives were identified, plaque-purified, and subcloned into Bluescript II KS (Stratagene). These three clones, designated as CL33, CL91, and CL99, contained inserts of 1.3, 1.5, and 0.8 kb, respectively; CL91 also contained a poly(A) tail. CL33 and CL91 were sequenced completely. The position of these clones in the ultimately derived sequence and that of the relevant clones described below are shown in Fig. 1.

Table I. Sequences of peptides derived from purified rat kidney 5-OPase and comparison with the sequence of the protein deduced from its cDNA Sequences are identical except where noted. Underlined residues are those derived from the cDNA sequence that align with residues which were not identified with certainty by peptide sequencing. Peptide Amino acid sequence Positions in cDNA sequence 1 IQTGPPHVEK 652-661 2 LVQGGVFQEEAVTEALRAP(G)K 886-906                      3 ??A(C)(S)G(T)N(N)(L)HDN(S)DLRAQVAANQK               907-932 4 ??RTVNLGGK 1223-1232

A 0.39-kb PstI/EcoRI fragment was prepared from the 5 end of CL33 and labeled with [-³²P]dCTP by nick translation (1 × 10⁸ cpm/µg) for use as a probe for the second screening of the same library. Duplicate filters were hybridized at 55 °C in 6 × SSC hybridization solution (same as above) with 1.0 × 10⁵ cpm of ³²P-labeled probe/ml of hybridization solution. After rinsing briefly in 2 × SSC, 0.5% SDS at room temperature, the filters were washed in 0.4 × SSC, 0.1% SDS for 40 min at 55 °C with one change of the wash buffer. Of the ~5 × 10⁵ clones that were screened, 32 positives were identified, plaque-purified, and DNA prepared. Their insert sizes ranged from 1.1 to 3.2 kb. Southern blot analysis revealed that 14 of them hybridized with an oligonucleotide probe (17 mer) which is close to the 3 end of CL33 and CL91. This result indicated that these 14 clones overlapped completely with CL33 and CL91. One of these 14 clones, CL241, was chosen for subcloning and 5 and 3 end sequencing analysis because it represented a relatively large insert (~2.0 kb). Another four clones (all contain inserts >2.0 kb), CL222, CL252, CL273, and CL282, were chosen from the 18 clones that did not hybridize with the oligonucleotide probe. CL273 and CL282, the two apparently most 5-extended clones, as well as CL241, were subjected to restriction mapping and complete sequencing. CL273 proved to be an artifact, as described further under "Results."

An 0.8-kb EcoRV/XbaI fragment was prepared from the 5 end of CL282 and used as a probe for further screening of the library. Fourteen positive clones were obtained. In order to quickly screen the most 5-extended clones, a 24-mer primer (antisense primer) complementary to nucleotides 100-123 of CL282 (nucleotides 744-764 in Fig. 2), was synthesized and used to amplify the 5-extended region of the 14 positive clones with PCR according to the manufacturer's instructions. The sense primer used here was one of the two primers of the gt11 cDNA insert Amplifier (Clontech). Three positive clones, CL341, CL342, and CL361, seemed to contain relatively longer sequences in the 5-end region and were subjected to subcloning, restriction mapping, and sequencing, although CL341 proved to be another artifact (see under "Results").

In order to obtain a complete cDNA clone, three antisense gene- specific primers (GSP1, GSP2, and GSP3, which are complementary to nucleotides 254-277, 744-764, and 1414-1434, respectively; Fig. 2) were designed and used to amplify the 5-cDNA end of 5-OPase from a premade library of rat kidney Marathon-Ready cDNAs (Clontech) with the provided adapter specific primer AP1 (18). PCR (30 cycles) was performed according to the manufacturer's instruction with the LD-PCR System (Boehringer Mannheim) in a Perkin-Elmer DNA Thermal Cycler 480 using the following program: 94 °C for 1.0 min, then 30 cycles of 94 °C for 30 s, 63 °C for 45 s, and 68 °C for 1.5 min. 5 µl of the PCR products were subjected to electrophoretic examination on a 1.2% agarose-EtBr gel. A secondary PCR reaction was performed following the same procedure described above except that 5 µl of the diluted (1:10) primary PCR product were used in place of the Marathon-Ready cDNAs as template, and 25 cycles were applied. After the secondary PCR amplification, the products were gel-purified, digested with ApaI/NotI (for CGSP2) or HincII/NotI (for CGSP3), subcloned into Bluescript II KS which had been previously digested with ApaI/NotI or HincII/NotI, and sequenced.

A charged nylon membrane containing mRNA from various rat tissues (Clontech) was used. The membrane was incubated in prehybridization buffer (5 × SSPE containing 10 × Denhardt's solution, 50% formamide, 2% SDS, and 100 µg/ml denatured fragmented salmon sperm DNA) at 42 °C with CL33, which was labeled with ³²P by nick translation (5 × 10⁸ cpm/mg). The membrane was washed twice for 10 min each with 2 × SSPE and 0.05% SDS at room temperature and twice for 40 min at 50 °C in 0.1 × SSPE and 0.1% SDS. Autoradiography was performed at 79 °C for 3 days.

An N-terminal truncated cDNA clone of 5-OPase was constructed by joining the overlapped clones of CL361, CL282, and CL241 using the unique restriction sites of HincII and AgeI (Fig. 1). The assembled 3.8-kb cDNA clone, which contains a stop codon at its 3 end, was excised from the recombinant Bluescript II KS by EcoRI digestion and ligated to pT7-7 (19) which had been digested with EcoRI. The resulting clone, pFCL361-241, which is truncated at the N-terminal of 5-OPase by 54 residues, is in the proper reading frame in the EcoRI site of pT7-7 and would subsequently be translated as a fusion protein linked through its amino terminus to the first 4 amino acids of the gene 10 protein.

Another N-terminal deleted clone (truncated by 850 residues at the N terminus of 5-OPase), pFCL33, was constructed directly by joining the cDNA insert of CL33 into pT7-7 at the EcoRI site. The resulting clone, pFCL33, would also subsequently be translated as a fusion protein linked through its amino terminus to the first 4 amino acids of the gene 10 protein.

Creation of the NdeI site at the start codon of 5-OPase was achieved by PCR amplification from rat kidney Marathon-Ready cDNAs using 5-CTCCAGCTTCAACCATATGGGCAGC-3 as the gene-specific primer. The LD-PCR amplification resulted in a full-length cDNA clone of 5-OPase (4.0 kb, as shown in Fig. 3B). This clone was digested with NdeI/PstI, yielding a 2.9-kb cDNA fragment that was truncated at the C-terminal region of 5-OPase by 302 amino acid residues and was ligated to pT7-7 which had previously been digested with NdeI/PstI. For subsequent expression as a fusion protein, the resulting clone (pFCPCR) was linked at its 3 end to the DNA sequence encoding the hexapeptide AQAYHR followed by a stop codon.

5 and 3 Marathon RACE of 5-oxoprolinase from rat kidney Marathon-Ready cDNAs.

The full-length clone was constructed by ligation of the NdeI/KpnI fragment of pFCPCR to pFCL361-241 which had been digested with NdeI/KpnI. The constructed full-length clone, pROPASE, is immediately downstream from the T7 promoter (10). Sequences representing the full-length and truncated recombinant 5-OPase were expressed in E. coli (BL21:DE3) as described (20).

RESULTS

The enzyme preparation obtained from step 9 of the purification procedure yields, as monitored by SDS-polyacrylamide gel electrophoresis, a dominant band of 140 kDa that comprises >90% of the protein and two minor bands of lower molecular weight. Approximately 600 µg of protein could be obtained from 500 g of frozen rat kidney with a specific activity of 72 units/mg. Table I shows the sequences of four Lys-C enzymatic peptides obtained from the purified enzyme. The amino acid sequences corresponding to these four peptides were subsequently found in the cDNA clone (Fig. 2).

Fig. 1 outlines the position in the cDNA sequence of the relevant clones used for sequence determination. By screening a rat kidney cDNA library with the end-labeled degenerate oligonucleotide probe encoding the partial sequence of peptide 1, three positive clones were initially obtained. Two of them, CL33 and CL91, were found to contain the longest sequence of the 3-untranslated region. CL91 also included a poly(A) tail. Screening of the same library using the 0.39-kb ³²P-labeled EcoRI/PstI fragment prepared from the 5 end of CL33 gave 32 positives. Of these, CL241, CL222, and CL282 were completely sequenced. Though CL273 was the largest (3.2 kb) and the most 5-extended, this clone was found to be an artifact at its 5 region on the basis of restriction mapping and sequencing; i.e. about two-thirds of the 5 terminal region of CL273 was from an unknown cDNA clone, as judged in part by the presence of a poly(A) tail in this region. CL341, the most 5-extended cDNA clone (2.4 kb) from the third screening (which used a probe from the 5 end of CL282), was also found to be incorrect; restriction mapping and sequencing of this clone indicated that a fragment of 0.6 kb at its 5 end was an artifact, as evidenced by the presence of a number of internal stop codons. CL324 and CL361 from the third sequence allowed determination of most of the remaining sequence.

The complete cDNA clone for the enzyme was obtained by LD-PCR amplification using the premade rat kidney Marathon-Ready cDNAs as templates. After secondary PCR amplification as described under "Experimental Procedures," the resulting PCR product generated a band of the predicted size after electrophoresis on a 1.2% agarose-EtBr gel (Fig. 3A). Sequencing of the clones of CGSP2 and CGSP3 revealed two completely overlapping cDNA fragments of the 5 end of 5-oxoprolinase, in which CGSP3 was more 5-extended than CGSP2 by 4 bases.

The sequence of the assembled 4.016-kb cDNA for rat kidney 5-OPase is shown in Fig. 2. It revealed an uninterrupted open reading frame encoding 1288 amino acid residues with a calculated molecular weight of 137,759, which agrees well with that previously estimated by SDS-PAGE (M_r = 142,000) (6). The 5-untranslated region of 105 nucleotides contains an in-frame stop codon. The first ATG (position 106) is presumed to be the initiation codon and conforms to the consensus sequence for an initiation codon context (21). The coding sequence ends with a termination codon (TGA) at position 3969, followed very closely by the polyadenylation signal AATAAA beginning at position 3981 and a 14-nucleotide poly(A) tail (Fig. 2).

All four independently determined peptide sequences are found in the deduced amino acid sequence (Fig. 2). The sequence also indicates five potential sites for N-glycosylation (N-X-S/T), although actual glycosylation has not been demonstrated. The calculated amino acid composition is in fair agreement with the amino acid analysis of the isolated protein (6), except for Asx, Glx, and Lys (data not shown). The predicted protein sequence was found to be unique when compared with the protein sequences given in the GenBank and SwissProt data bases, but strong sequence similarities to three other proteins were found (see under "Discussion").

Northern blot hybridization studies with nick-translated probe prepared from a fragment of 5-OPase (CL33) showed that the mRNA for the enzyme is well expressed in testis, kidney, and liver, whereas the mRNA levels in other tissues examined (brain, heart, lung, spleen, and muscle) were about 10% or less of that found in testis or kidney (Fig. 4). These findings are in general agreement with determinations of the activities of 5-OPase in these tissues (8). The size of the transcript in kidney (~4.4 kb) is a little smaller than that found in testis and liver (~5.0 kb). Minor bands of smaller size, particularly evident in the testis sample, probably arise from mRNA degradation or from nonspecific hybridization. It should be noted that the rat multiple tissue Northern blot (Clontech) used in this study had been probed several times before, so the strength of the hybridization signal does not represent the real level of the mRNA.

The expressed recombinant rat kidney 5-OPase and the expressed N-terminal and C-terminal truncated proteins gave bands of the predicted sizes when analyzed by SDS-gel electrophoresis and Western blot using the antibodies against the purified 5-OPase (Fig. 5, A and B). Also, recombinant 5-OPase and the 5-OPase isolated from rat kidney homogenate gave bands of apparently same size when detected by Western blot. These data provide further evidence that the cDNA clone obtained in this study corresponds to that of rat kidney 5-OPase. The C-terminal truncated recombinant 5-OPase (missing a C-terminal peptide of 243 residues) encoded by pFCPCR gave no detectable band on the Western blot (Fig. 5B), but its expression was readily seen when gels were stained with Coomassie Blue (Fig. 5A). This result suggests that the polyclonal sera principally contain antibodies that recognize denaturation-resistant epitopes within the C-terminal region of 5-OPase. Enzymatic activity analysis of the expressed recombinant rat kidney 5-OPase in the lysate of E. coli using standard procedures (see under "Experimental Procedures") indicated no significant increase in activity above the control.

DISCUSSION

The present work is the first carried out on the cloning and expression of 5-oxoprolinase. The deduced amino acid sequence of the rat kidney enzyme consists of 1288 residues with a calculated molecular weight of 137,759, which is close to the weight of 142,000 previously estimated from SDS-PAGE analysis of the isolated enzyme (6). Previous work (4, 6) in this laboratory also suggested that the native enzyme (M_r = 325,000, estimated by gel filtration) is composed of two subunits of identical molecular weight that are not held together by disulfide bonds. Since all of the four independently determined peptide sequences were found within the predicted protein sequence and the calculated amino acid composition was in fair agreement with the amino acid analysis of the isolated rat kidney enzyme, the data support the suggestion that the two subunits are identical.

Most of the cDNA sequence of 5-OPase presented here represents the overlapping cDNA clones that were obtained from successive screening of a gt11 rat kidney cDNA library. However, further screening of the same library with probes directed to the 5-terminal region failed to produce positive results. Accordingly, to determine the 5-terminal sequence of the enzyme, we turned to the rat kidney Marathon-Ready cDNAs. Marathon-Ready cDNAs are premade libraries of adapter-ligated double strand cDNA ready for use as templates in Marathon cDNA amplification, a unified method for performing rapid amplification of both 5- and 3-cDNA ends (RACE) from the same template (18) with the LD-PCR method (22). In the present studies, we completed the cDNA of rat kidney 5-OPase by amplifying its 5 end from a library of rat kidney Marathon-Ready cDNAs. Three primers, which were complementary to the known sequences at various regions of the cDNA, were designed and used as gene-specific primers to perform the 5 RACE. They each gave the product of the predicted size (Fig. 3A). Sequencing of CGSP2 and CGSP3 revealed that they were completely overlapped except for a several base extension at the 5 end of CGSP3. Sequencing of the 5 end of another 5 RACE product (Fig. 3B, lane 3) gave the same results as CGSP3.

The full-length (beginning just before the start codon; Fig. 3B, lane 1) and the 3 end cDNA of 5-OPase (Fig. 3B, lane 2) have also been amplified from Marathon-Ready cDNAs and their sequences confirmed by restriction mapping and DNA sequencing, giving the same results as obtained from the conventional screening of the gt11 cDNA library. This indicates that the library of rat kidney Marathon-Ready cDNAs contains the full-length cDNA of 5-OPase and that the cDNA clones from conventional screening of the gt11 cDNA library are consistent with those obtained from Marathon-Ready cDNAs by LD-PCR amplification. Thus, the cDNA clone of rat kidney 5-OPase obtained in this study has been checked by two different methods.

Western blot and standard SDS-PAGE analysis of the proteins encoded by the recombinant 5-OPase clones demonstrated that the full-length recombinant 5-OPase expressed in E. coli migrates at a position identical to that of endogenous rat kidney 5-OPase (Fig. 5), further demonstrating that the isolated cDNA corresponds to that encoding the rat kidney enzyme. Similar analysis of proteins encoded by the truncated recombinant cDNA clones revealed that recombinant proteins with intact C-terminal regions are specifically detected by the antiserum against the isolated rat kidney 5-OPase, whereas the C-terminal truncated recombinant proteins were not detected by the antiserum. The results indicate that the C-terminal 243 residues of 5-OPase contain the reactive denaturation-resistant epitopes for the anti-5-OPase serum and that other regions of the enzyme either do not contain such epitopes or that their epitopes are unreactive in the absence of the C-terminal region.

It is perhaps not surprising that expression of the rat kidney 5-OPase cDNA in E. coli did not result in a detectable increase in 5-OPase activity. The rat kidney enzyme is a very large homodimer in which the two subunits interact tightly without any disulfide bonds and might well not fold to give an enzymatically active protein in E. coli, at least under the conditions used here. Obtaining functional recombinant 5-OPase is clearly a prerequisite for mechanistic and further structural studies of this enzyme.

The unexpected result from this study is the demonstration of strong sequence similarities among rat kidney 5-OPase, the two bacterial hydantoinases, and the yeast protein YKL215C (Fig. 6). YKL215C is a hypothetical protein of 1287 residues encoded by the URA1-RSD1 intergenic region (23). The similarity between this sequence and that of the rat kidney enzyme is sufficiently strong (48.4% identity) to suggest that the yeast protein is also a 5-oxoprolinase. To understand the similarity to the bacterial hydantoinases, a comparison of the 5-oxoprolinase reaction and that catalyzed by the hydantoinases indicates the relationship between the chemical reactions involved (Fig. 7). Both reactions involve the hydrolysis of 5-membered rings via hydrolysis of their internal -CO-NH- bonds. HyuA is specific for D-5-substituted hydantoins, while HyuB is specific for the corresponding L isomers (24, 25). The amino-terminal half of rat kidney 5-oxoprolinase shows 26.6% identity with the amino-terminal region of HyuA, while the carboxyl-terminal half of the rat kidney enzyme shows 25.9% identity with the amino-terminal region of HyuB. These somewhat surprising relationships partially reflect the fact that HyuA and HyuB show no significant sequence similarities to each other (24, 25). Thus it is possible that the rat kidney enzyme evolved from an evolutionary fusion of these functionally similar but structurally different enzymes, or that the hydantoinases arose from an enzyme related to rat kidney 5-oxoprolinase. However, it is relevant that neither HyuA nor HyuB require ATP for ring hydrolysis, in contrast not only to 5-OPase, but also to a different bacterial hydantoinase that cleaves 5-substituted hydantoins (26) as well as to one that cleaves N-methylhydantoins (27). The difference among the bacterial hydantoinases in their requirement for ATP is surprising, and it will clearly be of interest to learn the structural relationship of rat kidney 5-OPase to the ATP-requiring hydantoinases.

The above raises the question of bacterial 5-oxoprolinase. 5-OPase from bacteria (P. putida) (4, 7), unlike that from rat kidney, is composed of two functionally different protein components, Component A and Component B. Neither component alone catalyzes the 5-OPase reaction, but the reaction is effectively catalyzed when the components are mixed. Component A is composed of two subunits, M_r = 65,500 and 50,000, and exhibits 5-oxo-L-proline-dependent ATPase activity, indicating this component can interact with both ATP and 5-oxo-L-proline. The role of Component B (M_r = 80,000) is uncertain, since it does not exhibit ATPase activity, and there is no evidence that it binds 5-oxo-L-proline. Of relevance here is the fact that the antiserum directed against the rat kidney enzyme strongly reacts with an E. coli component of ~60 kDa (Fig. 5B), suggesting that this component might be a subunit of E. coli 5-OPase Component A and raising the question of homology between the rat kidney and bacterial 5-oxoprolinases and the relationship of the bacterial 5-oxoprolinases to the bacterial hydantoinases. The sequence of bacterial 5-oxoprolinase will be an important clue in this evolutionary puzzle.